Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mihee Kim

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Cancers|June 13, 2025
Clinical Implication of Sequential Circulating Tumor DNA Assessments for the Treatment of Diffuse Large B-Cell LymphomaGa-Young Song, Joo Heon Park, Sae-Ryung Kang, et al.
Nature Cell Biology|February 23, 2010
The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1Masaaki Komatsu, Hirofumi Kurokawa, Satoshi Waguri, et al.
The Korean Journal of Internal Medicine|January 25, 2024
Prognostic Significance Of Sequential 18f-fdg Pet/Ct During Frontline Treatment Of Peripheral T Cell LymphomasGa-Young Song, Sung-Hoon Jung, Seo-Yeon Ahn, et al.
Cancer Immunology, Immunotherapy : CII|November 17, 2022
Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft modelJaya Lakshmi Thangaraj, Sung-Hoon Jung, Manh-Cuong Vo, et al.
Heliyon|March 25, 2024
Exploring cellular immunotherapy platforms in multiple myelomaManh-Cuong Vo, Sung-Hoon Jung, Van-Tan Nguyen, et al.
Cellular & Molecular Immunology|May 13, 2021
Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse modelJaya Lakshmi Thangaraj, Seo-Yeon Ahn, Sung-Hoon Jung, et al.
Clinical Nuclear Medicine|February 17, 2025
Prognostic Value of 18 F-FDG PET in Primary Central Nervous System Lymphoma : Assessing Interim Metabolic Response for Improving Patient StratificationGa-Young Song, Ho Cheol Jang, Mihee Kim, et al.
Frontiers in Oncology|February 14, 2024
Risk stratification for early mortality in newly diagnosed acute promyelocytic leukemia: a multicenter, non-selected, retrospective cohort studySuhyeon Kim, Jiye Jung, Seo-Yeon Ahn, et al.
The Korean Journal of Internal Medicine|June 9, 2023
The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabineMihee Kim, TaeHyung Kim, Seo-Yeon Ahn, et al.
Annals of Hematology|July 1, 2023
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015)Mihee Kim, Je-Jung Lee, Chang-Ki Min, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Cancers|June 13, 2025
Clinical Implication of Sequential Circulating Tumor DNA Assessments for the Treatment of Diffuse Large B-Cell LymphomaGa-Young Song, Joo Heon Park, Sae-Ryung Kang, et al.
Nature Cell Biology|February 23, 2010
The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1Masaaki Komatsu, Hirofumi Kurokawa, Satoshi Waguri, et al.
The Korean Journal of Internal Medicine|January 25, 2024
Prognostic Significance Of Sequential 18f-fdg Pet/Ct During Frontline Treatment Of Peripheral T Cell LymphomasGa-Young Song, Sung-Hoon Jung, Seo-Yeon Ahn, et al.
Cancer Immunology, Immunotherapy : CII|November 17, 2022
Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft modelJaya Lakshmi Thangaraj, Sung-Hoon Jung, Manh-Cuong Vo, et al.
Heliyon|March 25, 2024
Exploring cellular immunotherapy platforms in multiple myelomaManh-Cuong Vo, Sung-Hoon Jung, Van-Tan Nguyen, et al.
Cellular & Molecular Immunology|May 13, 2021
Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse modelJaya Lakshmi Thangaraj, Seo-Yeon Ahn, Sung-Hoon Jung, et al.
Clinical Nuclear Medicine|February 17, 2025
Prognostic Value of 18 F-FDG PET in Primary Central Nervous System Lymphoma : Assessing Interim Metabolic Response for Improving Patient StratificationGa-Young Song, Ho Cheol Jang, Mihee Kim, et al.
Frontiers in Oncology|February 14, 2024
Risk stratification for early mortality in newly diagnosed acute promyelocytic leukemia: a multicenter, non-selected, retrospective cohort studySuhyeon Kim, Jiye Jung, Seo-Yeon Ahn, et al.
The Korean Journal of Internal Medicine|June 9, 2023
The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabineMihee Kim, TaeHyung Kim, Seo-Yeon Ahn, et al.
Annals of Hematology|July 1, 2023
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015)Mihee Kim, Je-Jung Lee, Chang-Ki Min, et al.
Pageof 6